Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice

J Blackham, S Burns, S Cameron, P Cane, I Chrystie, D Churchill, J Clarke, P Easterbrook, M Zuckerman, D Goldberg, M Gompels, T Hale, L Lazarus, A Leigh Brown, C Loveday, AM Geretti, D Pillay, A Phillips, C Sabin, T HillP Kellam, D Dunn, K Porter, H Green, R Matthias, A Pozniak, P Tilston, I Williams, A Babiker, M Fisher, R Gilson, M Johnson, J Mortimer, B Peters, G Scullard, B Gazzard, L Bansi, C Smith, A Waters, D Crates, N Morgan, N Perry, A Pullin, W Harris, S Bulbeck, S Mandalia, J Dodds, N Fudge, A Rider, K Sinka, B Evans, V Delpech, N Larbalestier, K Gray, M Youle, F Lampe, H Gumley, C Chaloner, J Puradiredja, J Weber, C Owens, UK Collaborative Grp HIV Drug Resist, UK CHIC Study Grp

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice'. Together they form a unique fingerprint.

Medicine & Life Sciences